Source: International Congress 2015 – COPD: chronic disease and comorbidities
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Vlasios Vitsas (Athens, Greece), Vlasios Vitsas, Kardara Matina, Vasileiou Aliki, Koutsoukou Antonia, Michalopoulou Pinelopi, Orfanos Stylianos, Tsoukalas Georgios, Kotanidou Anastasia. Biomarkers in COPD- The role of resistin and leptin. Eur Respir J 2015; 46: Suppl. 59, 691

Member's Comments

No comment yet.

Related content which might interest you: Biomarkers in COPD exacerbation, the role of adiponectin Source: International Congress 2014 – Predictors Year: 2014 Blood eosinophils and outcomes in COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Circulating vasoactive intestinal peptide for diagnosis of exacerbation of COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Assessment of sputum prostaglandins and leukotrienes in COPD exacerbations Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Serum levels of leptin and visfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Different data in COPD Year: 2015 Serum periostin in asthma: A potential biomarker for stratification in severe treatment-resistant asthma Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Increased serum level of apelin in chronic obstructive pulmonary disease Source: International Congress 2015 – COPD: interesting notes Year: 2015 Serum sirtuin-1 is reduced in COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 Inflammatory markers (IL-6, suPAR) and arterial stiffness parameters in COPD patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Role of inflammatory biomarkers in COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 Serum periostin and exercise-induced asthma Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Fibrinogen and CRP biomarkers in patients with exacerbation of COPD group C and D Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Serum adiponectin in hospitalised patients with COPD: Relationship with peripheral muscle function, physical performance and readmissions Source: International Congress 2014 – Latest insights in physical activity, exercise testing and muscles Year: 2014 Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Inflammatory serum profiles are consistent across independent exacerbations in COPD patients with a history of frequent exacerbations Source: International Congress 2015 – COPD: interesting notes Year: 2015 Effect of tralokinumab on serum periostin and IgE levels in uncontrolled severe asthma Source: International Congress 2015 – Advances in the future treatment of severe asthma Year: 2015 Presence of progranulin in airway inflammation associated with COPD Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Variants of apelin gene and COPD Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma Year: 2016 Monitoring catalase activity in COPD exacerbations Source: International Congress 2016 – Airway biomarkers Year: 2016